High infection rates among younger adults suggest they either delay routine dental care and only seek treatment when conditions become severe, or face more barriers.
Researchers called for standardized health outcome descriptors to help bridge communication gaps in rheumatology care and improve shared decision-making.
Tocilizumab alone and in combination with methotrexate outperformed the latter drug in patients who did not adequately respond to conventional synthetic disease-modifying antirheumatic drugs.